Skip to content

Screening of Biomarkers and Related Mechanisms for RIX

Screening of Diagnostic Biomarkers and Related Mechanisms for Radiation-induced Xerostomia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07170358
Acronym
RIX
Enrollment
50
Registered
2025-09-12
Start date
2024-05-17
Completion date
2027-06-30
Last updated
2026-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Xerostomia Due to Radiotherapy (Disorder)

Keywords

Head and neck tumor, radiotherapy, biomarkers, xerostomia

Brief summary

A large number of patients undergoing radiotherapy and chemotherapy are suffering from dry mouth. Due to reduced saliva secretion, patients may experience symptoms such as difficulty chewing and swallowing. In severe cases, they may also experience pain and burning sensation in the oral mucosa, decreased taste, ulcers, which seriously affect the quality of life of patients. However, radiation-induced dry mouth lacks early objective predictive indicators (molecular biomarkers) and the mechanism is unclear. Only when patients experience clinical symptoms will symptomatic treatment be taken to alleviate them. Therefore, elucidating the mechanism of radiation-induced dry mouth syndrome (RIX) and achieving early prediction, detection, and intervention of RIX are crucial in improving the prognosis and quality of life of radiotherapy patients. It is urgent to seek early and precise detection targets in clinical practice to predict dry mouth caused by irreversible damage to salivary gland tissue. This study aims to collect blood samples from patients with severe dry mouth before and after radiotherapy and chemotherapy in clinical practice. Multiple omics techniques will be used to search for predictive molecular biomarkers for RIX, construct a predictive model, and verify the sensitivity and specificity of the biomarkers. The goal is to predict the occurrence of RIX early in clinical practice, intervene in advance, greatly improve the prognosis of radiotherapy and chemotherapy patients, and enhance their quality of life.

Interventions

RADIATIONRadiation Therapy

Radiotherapy for Head and Neck Cancer Patients

Sponsors

Second Affiliated Hospital, Zhejiang University, School of Medicine
Lead SponsorOTHER
The Tumor Hospital of Jiangsu Province
CollaboratorOTHER
The First Affiliated Hospital with Nanjing Medical University
CollaboratorOTHER
Jinling Hospital Affiliated to Nanjing University School of Medicine
CollaboratorUNKNOWN

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Histological diagnosis of head and neck cancer; * Plan to undergo curative treatment with radiotherapy alone or in combination with synchronous chemotherapy, immunotherapy, or targeted therapy; * Age greater than or equal to 18 years old, Fully understand the purpose and significance of this study, voluntarily participate and sign an informed consent form.

Exclusion criteria

* Metastatic diseases; * History of head and neck radiotherapy; * Severe dry mouth before radiotherapy; * Suffering from advanced chronic diseases: heart failure - New York Heart Association functional classification III/IV, renal failure - estimated glomerular filtration rate under 30mL/min/1.73m2, liver failure - Child Pugh score C or D.

Design outcomes

Primary

MeasureTime frameDescription
Resting saliva flow measurementFrom the start of radiotherapy to 3 months after completionWhen fasting in the morning, instruct the patient to gather saliva at the bottom of the mouth, lower their head and slightly open their mouth to allow the gathered saliva to naturally flow into the oral cup. Generally, collect for 10 minutes, with less than 1ml indicating mild dry mouth, less than 0.5ml indicating moderate dry mouth, and less than 0.1ml indicating severe dry mouth.

Secondary

MeasureTime frameDescription
Changes in Quality of Life and xerostomia Questionnaire ScoresFrom the start of radiotherapy to 3 months after completionAccording to the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-head and neck35(EORTC QLQ-H\&N35) questionnaire, dry mouth symptoms were scored and classified in patients with postoperative oral dryness after radiotherapy.In the dry mouth category, responses of "quite a bit" and "very much" and a total score difference of ≥ 10 points before and after treatment are defined as moderate to severe dry mouth.The higher the overall score, the worse the situation.
Comparison of Body Mass IndexFrom the start of radiotherapy to 3 months after completionMeasure the weight changes of patients before and after radiotherapy, weight and height will be combined to report BMI in kg/m\^2.

Countries

China

Contacts

CONTACTLei Jin
ljin666666@zju.edu.cn86+13868063666

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 10, 2026